Early Trial Data Shows SRK-015 Increases Myostatin Growth Factor Levels in SMA Patients
We discuss early trial data that shows SRK-015 increases myostatin growth factor levels up to 100-fold in SMA patients & Forums Director Kevin Schaefer reads an excerpt from Alyssa Silva’s latest colu...
10 Jan 20207min
Volunteering As A Reward & Humorous Interactions With People
In her most recent column, I Don’t Need to Win to Be a Winner: Volunteering Is Its Own Reward, Halsey explains how her volunteer efforts have been recognized. Halsey not only works with a great group ...
8 Jan 20205min
#49 - Interview With Ashley Fox
In episode 49, host Kevin Schaefer interviews Ashley Fox from Southern California. Ashley is currently studying psychology at a community college, and she has SMA type 2. She talks about growing up wi...
7 Jan 202029min
Asuragen States New Screening Kit Analyzes SMN1 and SMN2 Genes in the Lab & Being Grateful
We discuss how Asuragen is stating that a new screening kit, quickly and thoroughly analyzes SMN1 and SMN2 genes in the lab. & With all the variables that can come into play getting her Spinraza injec...
6 Jan 20206min
AveXis Unaware of the Cause of Inflammation that Led to the STRONG Trial Hold & 2019 Highlights
We discuss how AveXis is unaware of the cause of inflammation, that led to the STRONG trial hold of AVXS-101. Forums Director Kevin Schaefer shares some of his highlights from this year. Are you inte...
20 Des 201913min
#48 - Roundtable Discussion December 2019
In episode 48, hosts Kevin Schaefer and Michael Morale discuss the latest news regarding Roche and Genentech’s experimental therapy risdiplam. We also talk with our very own DeAnn Runge. DeAnn discuss...
17 Des 201924min
#47 - Interview With James Ian
In episode 47, host Kevin Schaefer talks with James Ian from Los Angeles, California. James is a singer, songwriter, and actor, and he has SMA Type 3. Kevin and James talk about music, living with SMA...
3 Des 201936min
#46 Roundtable Discussion - Discussion for November 2019
In episode 46, hosts Kevin Schaefer and Michael Morale discuss the latest news regarding Roche and Genentech’s experimental therapy Risdiplam. We also talk about AveXis’ decision to put its STRONG tri...
19 Nov 201927min
